Celldex Therapeutics (CLDX) Amortization of Goodwill (2018)
Celldex Therapeutics (CLDX) posted quarterly Amortization of Goodwill of -$24000.0 for Q2 2018, down 100.03% quarter-over-quarter from $91.0 million in Q1 2018.
Celldex Therapeutics (CLDX) Amortization of Goodwill (2018) Analysis & Trends
Celldex Therapeutics' Amortization of Goodwill history runs 1 years deep, the most recent figure standing at -$24000.0 for Q2 2018.
- In Q2 2018, Amortization of Goodwill changed N/A year-over-year to -$24000.0; the TTM figure through Dec 2018 stood at $91.0 million (changed N/A YoY), while the FY2018 annual figure was $91.0 million, changed N/A from the prior year.
- Amortization of Goodwill for Q2 2018 stood at -$24000.0, down from $91.0 million in the prior quarter.
- The five-year high for Amortization of Goodwill was $91.0 million in Q1 2018, with the low at -$24000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -24,000.00 |
| Jun 30, 2018 | -24,000.00 |
| Mar 31, 2018 | 91.00 Mn |
| Mar 31, 2018 | 91.00 Mn |